2021 CONQUER CANCER LONG-TERM INTERNATIONAL FELLOWSHIP (LIFe)
2021 CONQUER CANCERLONG-TERM INTERNATIONALFELLOWSHIP (LIFe)REQUEST FOR PROPOSALSLast Updated: June 29, 2020Application Deadline: January 14, 2021Conquer Cancer , the ASCO Foundation2318 Mill Road, Suite 800Alexandria, VA 22314grants@conquer.orgPlease visit asco.org/LIFe for the most up-to-dateversion of the Request for Proposals.About Conquer CancerConquer Cancer, the ASCO Foundation, funds research for every cancer, every patient, everywhere. In1964, seven oncologists created the American Society of Clinical Oncology (ASCO), now a globalnetwork of nearly 45,000 cancer professionals. As ASCO’s foundation, we support groundbreakingresearch and education so both doctors and patients have the resources they need.For more information, visit CONQUER.ORG.
2021 Long-term International Fellowship (LIFe)Request for ProposalsTable of ContentsPurpose . 3Funding Available . 3Eligibility Criteria . 3Physician Payments Sunshine Act . 4Compliance with Applicable Legal Requirements. 5Peer Review of Applications . 6Key Dates . 6Application Changes . 6Award Notification . 7Application Information Use and Sharing . 7Application Procedures . 8Application Guide. 81. Applicant Information (required) . 92. Project Information (required) . 93. Mentor Recommendation (required). . 114. Personal Statement Form (required). . 135. Budget (required). . 136. Publications (optional). 147. Applicant’s Biosketch (required). 158. Letter of Recommendation from Home Institution (required) . 159. Institution Approval (required) . 1610.Review and Submit (required). . 16APPLICATION CHECKLIST . 17Appendix A. World Bank Country Classification . 18Appendix B. Terms & Conditions . 20Appendix C. Helpful Tips for Using the Application Portal . 25Getting Started . 25Navigating the Application . 25Receiving Notifications . 26Uploading a Document . 26Requesting a Recommendation . 272
2021 Long-term International Fellowship (LIFe)Request for ProposalsPurposeThe Conquer Cancer Long-term International Fellowship (LIFe) provides early-career oncologists in lowto middle-income countries the support and resources needed to advance their training by deepeningtheir relationship with a mentor in the United States, Canada, or European Union (EU). During a oneyear Fellowship, the recipients receive valuable training and experience, which they will use to effectchange in cancer care in their home country. Fellowships are a combination of clinical training and clinicaland laboratory research in accordance with institutional rules and regulations. Recipients are expectedto return to their home institutions within one year of completing the Fellowship and disseminate theknowledge they have gained.Funding AvailableFor 2021, one Fellowship is available for a recipient from any country categorized by the World Bank asLow-Income, Lower-Middle-Income, or Upper-Middle-Income (see Appendix A for the list of countries)working in any cancer-related specialty area. Additional Fellowships may be awarded as fundingbecomes available. Fellowships are given based on individual merit and availability of funds.The Fellowship total is 115,000 USD for one year and will be paid in two equal installments. Any costsin excess of 115,000 are the responsibility of the host institution.Funds will be paid to the U.S., Canadian, or European Union institution that is hosting the LIFe recipientprior to the Fellowship start date. The host institution will be responsible for the administrative andfinancial management of the Fellowship. Any funds not spent on the Fellowship will be returned toConquer Cancer.Eligibility CriteriaApplicants must meet the following criteria in order to qualify for the LIFe:1. Must be a Full Member of ASCO, or a pending member awaiting acceptance. To apply for newmembership, or to renew an existing membership, go to http://www.asco.org/membership.2. Must be a physician (MD, DO, or international equivalent) who has completed a subspecialty trainingprogram (such as hematology-oncology fellowship or radiation oncology residency) or the equivalent.3. Must be a citizen of a country categorized by the World Bank as Low-Income, Lower-Middle-Income,or Upper-Middle-Income (see Appendix A for the list of countries).4. Must have less than 10 years of experience in the field of oncology.5. Must not have received more than one year of training in the United States, Canada, or the EuropeanUnion (for instance, attended medical school, participated in internships, fellowships, researchpositions or residency programs).6. Must not already be at the host institution at the time of application submission. This Fellowshipcannot be used to extend an existing fellowship or program of work.7. Must commit to returning to their home country within one year following the completion of theFellowship.8. Must have a pre-existing relationship with a mentor who is a Full Member of ASCO and is employedat a U.S., Canadian, or E.U. institution with sufficient infrastructure to provide for a one-yearfellowship.3
2021 Long-term International Fellowship (LIFe)Request for ProposalsPlease note that applicants who receive the LIFe will be required to:1.2.3.4.Possess and keep current a valid passport issued by their country of citizenship;Obtain a valid visa and provide evidence to Conquer Cancer of their visa status;Comply with the requirements governing their stay in the U.S., Canada, or the E.U.; andMaintain a legal visa status throughout the duration of the Fellowship.LIFe recipients must have visa sponsorship for the full period of the fellowship. Funds will not bedisbursed to the host institution without proof of a valid visa. Questions about sponsorship andacceptance of foreign nationals to a fellowship program, or visa application requirements, should be sentto the host institution. Conquer Cancer does not sponsor visas.Conquer Cancer reserves the right to evaluate and determine an applicant’s eligibility based onthe information and justifications included in the application materials. Questions about eligibility,application process, and application requirements should be sent via email to grants@conquer.org.Physician Payments Sunshine ActThe Physician Payments Sunshine Act, or “Sunshine Act”, is part of the Patient Protection and AffordableCare Act (health care reform) that passed in 2010.The law is designed to bring transparency to financialrelationships between physicians, teaching hospitals, and healthcare companies. More information aboutthe Sunshine Act can be found at ne-act-additional.The Sunshine Act requires manufacturers of pharmaceutical drugs and devices, as well as grouppurchasing organizations, to report payments or transfers of value made to CMS-designated teachinghospitals and U.S. licensed physicians. (Please see the following excerpt from the Sunshine Act FinalRule that defines physician according to this law. If there are any questions regarding reportability, pleasetalk with your institution. “As required by section 1128G(e)(11) of the Act, we proposed to define‘‘physician’’ as having the meaning set forth in section 1861(r) of the Act, which includes doctors ofmedicine and osteopathy, dentists, podiatrists, optometrists, and chiropractors, who are legallyauthorized to practice by the State in which they practice.”) Reports are made to the Centers for Medicareand Medicaid Services (CMS), a government agency.Conquer Cancer understands that payments made through this award may be reportable under theSunshine Act as indirect payments or transfers of value because these awards are funded by companiesthat are considered manufacturers of pharmaceutical drugs and devices and/or group purchasingorganizations.Conquer Cancer has entered into agreements with the supporters of this award that require that ConquerCancer provide reportable information under the Sunshine Act. U.S.-LICENSED PHYSICIANS OR CMSDESIGNATED TEACHING HOSPITALS WHO ARE PARTICIPANTS IN LONG-TERM4
2021 Long-term International Fellowship (LIFe)Request for ProposalsINTERNATIONAL FELLOWSHIPS MAY BE REPORTED ON THE CMS OPEN PAYMENTS WEBSITEAS HAVING RECEIVED PAYMENTS OR TRANSFERS OF VALUE FROM MANUFACTURERS OFPHARMACEUTICAL DRUGS AND/OR DEVICES. If there are any questions about reporting due to theSunshine Act, please contact Gray Ladd, Manager, Grant Compliance, at 571-483-1700 oroperations@conquer.org.Disclaimer: The information on this section is not intended to provide legal advice. For legal adviceconcerning the Sunshine Act, the applicant must consult his/her institution or legal counsel.For more information, see Terms and Conditions located in Appendix B.Compliance with Applicable Legal Requirements (Applies to Non-U.S. Institutions and Entities)The award of the LIFe is subject to applicable financial and legal requirements, including but not limitedto United States laws addressing foreign corrupt practices and economic and trade sanctions andembargoes (including but not limited to those administered by the Office of Foreign Assets Control of theU.S. Department of the Treasury). Notwithstanding any other provision in this this Request for Proposals,any grant award is contingent on Conquer Cancer’s ability to transfer grant funds to the sponsoringinstitution and/or individual(s) and support the research project to be conducted by the applicant incompliance with all applicable legal requirements. Conquer Cancer will not accept applications and/ormake grant awards to sponsoring institutions or individuals in those countries that are subject toU.S. sanctions or that require Conquer Cancer to obtain a license from the Office of ForeignAssets Control. If it is impossible or inadvisable for Conquer Cancer, in its sole and absolute discretion,to transfer grant funds to the sponsoring institution and/or individual(s) pursuant to applicable legalrequirements, the grant will not be awarded to the sponsoring institution and/or individual. If, afterpayment of the first installment of a grant award, it becomes impossible or inadvisable for ConquerCancer, in its sole and absolute discretion, to transfer grant funds to the sponsoring institution and/orindividual(s) pursuant to applicable legal requirements, then Conquer Cancer shall have no obligation topay additional installments of the grant award. It is the responsibility of the sponsoring institution and theapplicant to provide Conquer Cancer with the information or lawful means that permit Conquer Cancerto transfer the grant funds in compliance with all legal requirements.Among the resources available to evaluate compliance with requirements administered by the Office ofForeign Assets Control are: Pages/default.aspx Programs/Pages/Programs.aspx SDN-List/Pages/default.aspxAdditional Terms and Conditions are located in Appendix B.5
2021 Long-term International Fellowship (LIFe)Request for ProposalsPeer Review of ApplicationsApplications are reviewed for completeness, and selection is made by the Conquer Cancer LIFeSubcommittee, which consists of current and/or former members of Conquer Cancer Grants SelectionCommittee and ASCO’s International Affairs Committee.Selection will be made using the following criteria: High level of oncologic need in applicant’s home country.Strong merit and potential of applicant including clinical training, board certification, scholarlyactivity, and limited training (less than one academic year) in the U.S., Canada, or the EuropeanUnion.Fellowship plan which includes didactic opportunities (tumor board, research meetings) andclinical shadowing experience.An applicable, achievable, and publishable research project.Support from the home institution including ability to assist the applicant with implementing theresults of the research project and to continue researching in the area of interest.A host with strong academic and professional status and a background in the area of fellowshipresearch focus who agrees to provide appropriate supervision to the applicant over the course ofthe fellowship.A host institution with applicable academic focus, accreditation, and an active clinical fellowshipprogram.Key DatesOnline Applications Open:Full Applications Due:Award Notification Date:Grant Term:July 1, 2020January 14, 2021 (11:59 PM ET)April 2021July 1, 2021 – June 30, 2022**Requests for alternate start dates will be reviewed on a case-by-case basis.Application ChangesThe Principal Investigator must notify Conquer Cancer immediately by sending an email togrants@conquer.org if any of the following condition applies from application submission through awardnotification:1. Withdrawal of Application. Send an email to grants@conquer.org to inform the ConquerCancer Grants and Awards team of the reason(s) for withdrawing the application. The emailshould include the Principal Investigator’s name, the title of the proposal, and the reason forwithdrawing the application.2. Change of Institution or Position. The Principal Investigator has a career plan change, leaveshis/her current position in the Applicant Organization, or is unable to meet the eligibilityrequirements of this RFP. If the applicant is selected to receive an award, Conquer Cancerhas the right in its sole discretion to withdraw the award.6
2021 Long-term International Fellowship (LIFe)Request for Proposals3. Change in Proposal (Scope, Timeline, Budget, etc.). The Principal Investigator has significantchanges in the submitted proposal affecting aims, research strategy, timeline, and/or budget.If Conquer Cancer is notified of the change in proposal after the Principal Investigator isnotified of an award, Conquer Cancer has the right in its sole discretion to withdraw the award.Award NotificationApplicants can expect to be notified in April 2021 via email. All communication regarding applications,including award notifications, will be sent to the preferred email address on file. For questions, pleaseemail grants@conquer.org.Application Information Use and SharingConquer Cancer may use and process the information submitted through this application form for severalpurposes, including but not limited to: 1) evaluating the application, 2) communicating with you regardingyour application and other opportunities that may be of interest to you, 3) publishing information regardingConquer Cancer’s grants and awards program, including through third party databases, 4) informingConquer Cancer’s grant making strategies and policies, and 5) for other legitimate purposes in keepingwith Conquer Cancer’s Privacy Policy and charitable mission. Information submitted through thisapplication form will be kept on secure servers accessible to Conquer Cancer personnel and third partiesauthorized by Conquer Cancer to perform functions on Conquer Cancer’s behalf.In addition, by submitting an application form to Conquer Cancer, the applicant grants Conquer Cancerthe right to use all application information submitted, outside of the research proposal, for any purpose.The details of research proposals submitted are considered confidential property of the applicant.Conquer Cancer is permitted to share research proposals with Conquer Cancer staff and reviewers, thirdparty contractors, and potential supporters, and Conquer Cancer will require all to maintain theconfidentiality of such proposals.If an applicant is selected for an award, the applicant grants Conquer Cancer permission to depositgrantee information collected in any documents or communications related to the application (includingbut not limited to investigator name, degree(s), clinical specialty, Open Researcher and Contributor ID(ORCID), institution and institutional information, project title, abstract, grant start date and duration, andgrant amount) into the Health Research Alliance (HRA) online database (HRA Analyzer) of privatelyfunded grants, the Dimensions database, or any other similar database.If an applicant is deemed fundable but Conquer Cancer does not have funding available, the applicantgrants Conquer Cancer permission to share the full proposal to potential supporters.7
2021 Long-term International Fellowship (LIFe)Request for ProposalsApplication ProceduresAll applications must be submitted in accordance with the requirements and instructions of this Requestfor Proposals (RFP). All application materials must be in English and must be submitted online throughthe ASCO and Conquer Cancer applicatio
The Physician Payments Sunshine Act, or “Sunshine Act”, is part of the Patient Protection and Affordable Care Act (health care reform) that passed in 2010.The law is designed to bring transparency to financial relationships between physicians, teaching hospitals, and healthcare companies. More information about
Cormen: Algorithms Unlocked, pp 40-59 (mergesort, quicksort) Rosen: Chapter 8.3: Divide-and-Conquer Algorithms and Recurrence Relations Objective: Analyzing Divide and Conquer Algorithms 1.Introducing sorting 2.Divide and Conquer 3.Divide and Conquer example: Merge Sort 4.Analyzing Di
Ovarian cancer is the seventh most common cancer among women. There are three types of ovarian cancer: epithelial ovarian cancer, germ cell cancer, and stromal cell cancer. Equally rare, stromal cell cancer starts in the cells that produce female hormones and hold the ovarian tissues together. Familial breast-ovarian cancer
Review of the basic superfast divide-and-conquer eigensolver. We 140 rst brie y summarize the basic superfast divide-and-conquer eigensolver in [44], 141 which generalizes the classical divide-and-conquer method for tridiagonal matrices 142 to HSS matrices. 143 A symmetric HSS matrix A[54] may be de ned with the aid of a postordered full
As the Chair and Co-Chair of the Kansas Cancer Partnership (KCP), we are pleased to provide . you with the 2017-2021 Kansas Cancer Prevention and Control Plan. This plan is the result of . Breast Biopsies Breast Cancer Cervical Cancer Colorectal Cancer Lung Cancer Prostate Cancer. Post-Diagnosis & Quality of Life throughout the Cancer Journey.
cancer, pancreatic cancer, breast cancer, lung cancer, liver cancer, kidney cancer, brain cancer & brian tumors, lymphoma, blood diseases, bone cancer & all types of viruses Used externally as a skin cancer treatment, treating carcinoma, melanoma, warts, moles & as a drawing salve People with in-operable cancers sent home to die have used black
Conquer Cancer, the ASCO Foundation, funds research for every cancer, every patient, everywhere. In 1964, seven oncologists created the American Society of Clinical Oncology (ASCO), now a global network of nearly 45,000 cancer professionals. As ASCO’s foundation, we support groundbreaking . Table of Contents
Capital Territory Cancer Council Victoria Cancer Epigenetics Society Cancer Foundation of India Cancer Research Malaysia Cancer Society of Madhya Pradesh Cancer Society of Maldives Cancer Warriors Foundation Children’s
Cancer incidence—Cancer deaths 2. Pathogenetic factors: a balance of risks 3. Clinical effects of cancer 4. Death in cancer 5. Grading and Staging 6. Diagnosis? Cancer Age Environment Heredity-cancer mortality peak 55-75-under age 15, cancer causes approx. 10% of all deaths-cancer w/ ag
